CATEGORIES
Kategorier
![Prof. Christian Wolfrum to join NTU as Deputy President and Provost Prof. Christian Wolfrum to join NTU as Deputy President and Provost](https://reseuro.magzter.com/100x125/articles/11639/1979239/aFQSj2cXo1738327652897/PROF-CHRISTIAN-WOLFRUM-TO-JOIN-NTU-AS-DEPUTY-PRESIDENT-AND-PROVOST.jpg)
Prof. Christian Wolfrum to join NTU as Deputy President and Provost
Nanyang Technological University, Singapore (NTU Singapore) has announced that Professor Christian Wolfrum, an eminent biomedical scientist, will be joining the University as the next Deputy President and Provost.
![Japan suggests addition of PVA into drugs for strong antitumour activity Japan suggests addition of PVA into drugs for strong antitumour activity](https://reseuro.magzter.com/100x125/articles/11639/1979239/L7QBK8c9t1738327954522/JAPAN-SUGGESTS-ADDITION-OF-PVA-INTO-DRUGS-FOR-STRONG-ANTITUMOUR-ACTIVITY.jpg)
Japan suggests addition of PVA into drugs for strong antitumour activity
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children's glue.
!["Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly" "Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"](https://reseuro.magzter.com/100x125/articles/11639/1979239/Bh4IoWqD71738326641256/DEMAND-FOR-SKILLED-MEDTECH-PROFESSIONALS-IN-THE-ASIA-PACIFIC-REGION-IS-GROWING-RAPIDLY.jpg)
"Demand for skilled medtech professionals in the Asia Pacific region is growing rapidly"
2024 saw Japanese medtech firm Olympus receiving approval for the company's first cloud-based AI endoscopy devices in the US and Europe, marking a significant milestone in Olympus' efforts to enhance clinical outcomes and operational efficiency in endoscopy, paving the way to launch its upcoming endoscopy solution, the “Intelligent Endoscopy Ecosystem”.
![BeiGene names Giancarlo Benelli as Head of Europe biz BeiGene names Giancarlo Benelli as Head of Europe biz](https://reseuro.magzter.com/100x125/articles/11639/1979239/dtWtyXs321738327727847/BEIGENE-NAMES-GIANCARLO-BENELLI-AS-HEAD-OF-EUROPE-BIZ.jpg)
BeiGene names Giancarlo Benelli as Head of Europe biz
BeiGene, a Hong Kong-headquartered oncology company that intends to change its name to BeOne Medicines Ltd., has announced the appointment of Giancarlo Benelli as Senior Vice President and Head of Europe, effective January 1.
![Korea develops innovative injectable adhesive hydrogel for bone regeneration Korea develops innovative injectable adhesive hydrogel for bone regeneration](https://reseuro.magzter.com/100x125/articles/11639/1979239/3Ds0USfx91738327790862/KOREA-DEVELOPS-INNOVATIVE-INJECTABLE-ADHESIVE-HYDROGEL-FOR-BONE-REGENERATION.jpg)
Korea develops innovative injectable adhesive hydrogel for bone regeneration
A research team from South Korea-based Pohang University of Science and Technology or POSTECH's Department of Chemical Engineering and Graduate School of Convergence Science and Technology, along with the Department of Chemical Engineering, has developed an innovative injectable adhesive hydrogel for bone regeneration.
![When Clinical Trials Suffer From 'Complicated' Interactions When Clinical Trials Suffer From 'Complicated' Interactions](https://reseuro.magzter.com/100x125/articles/11639/1979239/NXkS_2pHM1738327122349/WHEN-CLINICAL-TRIALS-SUFFER-FROM-COMPLICATED-INTERACTIONS.jpg)
When Clinical Trials Suffer From 'Complicated' Interactions
Diversity in culture, language, and data gathering methods will further increase the difficulty of clinical trials as they become more international, particularly with the growing number of sites being employed across China, Japan, South Korea, and India.
![Dr Krishna M Ella receives prestigious INSA India fellowship Dr Krishna M Ella receives prestigious INSA India fellowship](https://reseuro.magzter.com/100x125/articles/11639/1979239/ewbWvQ-3l1738327520276/DR-KRISHNA-M-ELLA-RECEIVES-PRESTIGIOUS-INSA-INDIA-FELLOWSHIP.jpg)
Dr Krishna M Ella receives prestigious INSA India fellowship
Dr Krishna Ella, a distinguished scientist, co-founder and Executive Chairman of Bharat Biotech International, has been recognised with the prestigious India Fellowship of the Indian National Science Academy (INSA) for the year 2025, for his contributions to new knowledge, discoveries, development of new vaccine technologies, noteworthy improvement in existing technologies.
![Bruker launches infrared imaging microscope for pharma and life science research Bruker launches infrared imaging microscope for pharma and life science research](https://reseuro.magzter.com/100x125/articles/11639/1979239/AOv9T23_N1738328062423/BRUKER-LAUNCHES-INFRARED-IMAGING-MICROSCOPE-FOR-PHARMA-AND-LIFE-SCIENCE-RESEARCH.jpg)
Bruker launches infrared imaging microscope for pharma and life science research
US-based Bruker Corporation has announced the launch of the LUMOS II ILIM, a quantum cascade laser (QCL) based infrared (IR) imaging microscope.
![Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities](https://reseuro.magzter.com/100x125/articles/11639/1979239/vrAMheQwA1738328031280/QIAGEN-INCREASES-QIACUITY-DIGITAL-PCR-HIGHORDER-MULTIPLEXING-CAPABILITIES.jpg)
Qiagen increases QIAcuity digital PCR high-order multiplexing capabilities
Qiagen has announced a significant increase in the powerful capabilities of its QIAcuity Digital PCR (dPCR) system with a more than two-fold increase in the number of targets that can be simultaneously analysed from a single biological sample.
![Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers](https://reseuro.magzter.com/100x125/articles/11639/1979239/5sZt4mdv41738328195356/REPLIGEN-UNVEILS-ADVANCED-UVBASED-VARIABLE-PATHLENGTH-TECHNOLOGY-SYSTEM-FOR-BIOPHARMA-MANUFACTURERS.jpg)
Repligen unveils advanced UV-based Variable Pathlength Technology system for biopharma manufacturers
US-based Repligen Corporation has announced the commercial launch of its CTech SoloVPE PLUS System, the most advanced UV-based Variable Pathlength Technology system now available to biopharmaceutical manufacturers.
![Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation](https://reseuro.magzter.com/100x125/articles/11639/1979239/B-2DgCGDg1738328287035/BIOTECHNE-AND-WATERS-INK-COMARKETING-AGREEMENT-FOR-BIOTHERAPEUTIC-CHARACTERISATION.jpg)
Bio-Techne and Waters ink comarketing agreement for biotherapeutic characterisation
American life sciences company Bio-Techne Corporation, a leader in automated platforms for biotherapeutic characterization, has announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes.
![Singapore appoints Tan Chong Meng as Chairman of National University Health System Singapore appoints Tan Chong Meng as Chairman of National University Health System](https://reseuro.magzter.com/100x125/articles/11639/1979239/xwjutVSO81738327583227/SINGAPORE-APPOINTS-TAN-CHONG-MENG-AS-CHAIRMAN-OF-NATIONAL-UNIVERSITY-HEALTH-SYSTEM.jpg)
Singapore appoints Tan Chong Meng as Chairman of National University Health System
The Minister for Health has appointed Tan Chong Meng as the Chairman of the Board of the National University Health System (NUHS) from January 1, 2025 to December 31, 2027.
!["There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility" "There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"](https://reseuro.magzter.com/100x125/articles/11639/1979239/PizqfZqsJ1738326127789/THERE-IS-A-NEED-FOR-PHARMACEUTICAL-COMPANIES-TO-BUILD-HCP-RELATIONSHIPS-BACKED-BY-SCIENTIFIC-CREDIBILITY.jpg)
"There is a need for pharmaceutical companies to build HCP relationships, backed by scientific credibility"
Docquity, headquartered in Singapore, is Southeast Asia's largest professional network for verified healthcare professionals (HCPs), connecting over 410,000 doctors across the region.
![Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields](https://reseuro.magzter.com/100x125/articles/11639/1979239/tBHjXNZTp1738327833669/SINGAPORE-BOOSTS-CHEMOTHERAPY-UPTAKE-IN-BREAST-CANCER-TREATMENT-WITH-LOCALISED-MAGNETIC-FIELDS.jpg)
Singapore boosts chemotherapy uptake in breast cancer treatment with localised magnetic fields
Researchers at the National University of Singapore (NUS) have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects.
![APAC takes Centre stage in Al-Driven Drug Discovery APAC takes Centre stage in Al-Driven Drug Discovery](https://reseuro.magzter.com/100x125/articles/11639/1979239/29BinNlfk1738322715431/APAC-TAKES-CENTRE-STAGE-IN-ALDRIVEN-DRUG-DISCOVERY.jpg)
APAC takes Centre stage in Al-Driven Drug Discovery
The Asia-Pacific (APAC) region is rapidly emerging as a leader in Al-driven drug discovery, fuelled by robust research ecosystems and strong industry collaboration.
![UK declares biggest investment of £126 M into hospices UK declares biggest investment of £126 M into hospices](https://reseuro.magzter.com/100x125/articles/11639/1979239/g6hBZclvE1738322483468/UK-DECLARES-BIGGEST-INVESTMENT-OF-126-M-INTO-HOSPICES.jpg)
UK declares biggest investment of £126 M into hospices
The biggest investment in a generation for hospices has been announced by the UK government, ensuring that hospices can continue to deliver the highest quality end-of-life care possible for their patients, families, and loved ones.
![Universities in China & Pakistan ink MoU for advanced research in health sciences Universities in China & Pakistan ink MoU for advanced research in health sciences](https://reseuro.magzter.com/100x125/articles/11639/1979239/3sfSI1qfv1738327412871/UNIVERSITIES-IN-CHINA-PAKISTAN-INK-MOU-FOR-ADVANCED-RESEARCH-IN-HEALTH-SCIENCES.jpg)
Universities in China & Pakistan ink MoU for advanced research in health sciences
The School of Medicine, Shihezi University, Xinjiang, China, and the Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan, have signed a landmark Memorandum of Understanding (MoU) to foster collaboration in cutting-edge scientific research and academic exchange.
![Australia manufactures 3D printed scaffolding to rebuild jaw bones Australia manufactures 3D printed scaffolding to rebuild jaw bones](https://reseuro.magzter.com/100x125/articles/11639/1979239/43VpsOTAx1738327919699/AUSTRALIA-MANUFACTURES-3D-PRINTED-SCAFFOLDING-TO-REBUILD-JAW-BONES.jpg)
Australia manufactures 3D printed scaffolding to rebuild jaw bones
Clinicians have successfully used custom-made 3D printed bone scaffolds, printed on-site at The University of Queensland (UQ) in Australia, to rebuild part of a man's jawbone.
![Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund](https://reseuro.magzter.com/100x125/articles/11639/1979239/KNIz96l4T1738321810500/ABU-DHABI-ANNOUNCES-AED-19-M-IN-GRANTS-THROUGH-HEALTHCARE-RESEARCH-AND-INNOVATION-FUND.jpg)
Abu Dhabi announces AED 19 M in grants through Healthcare Research and Innovation Fund
The Department of Health - Abu Dhabi (DOH), the regulator of the healthcare sector in the Emirate, in partnership with the Authority of Social Contribution - Ma'an, the Abu Dhabi Government's dedicated platform that connects the government, private sector, and wider community to address key social priorities, has awarded over AED 19 million in grants through the Healthcare Research and Innovation Fund.
![Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria](https://reseuro.magzter.com/100x125/articles/11639/1979239/YwYf2nu8j1738322344055/GAVI-FACILITATES-DONATIONS-OF-MPOX-VACCINE-DOSES-WITH-FIRST-DELIVERY-TO-NIGERIA.jpg)
Gavi facilitates donations of mpox vaccine doses, with first delivery to Nigeria
A shipment of 11,200 doses, donated by the United States of America and facilitated by Gavi, the Vaccine Alliance, were recently shipped to Abuja, Nigeria.
![Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases](https://reseuro.magzter.com/100x125/articles/11639/1979239/qYlM6VDJ01738321996015/FUJIREBIO-AND-EISAI-TO-ESTABLISH-DIAGNOSTIC-TECHNOLOGIES-FOR-NEURODEGENERATIVE-DISEASES.jpg)
Fujirebio and Eisai to establish diagnostic technologies for neurodegenerative diseases
Fujirebio Holdings, a wholly-owned subsidiary of H.U. Group Holdings, Inc., and Eisai Co., in Japan, have entered into a Memorandum of Understanding (MoU) for the joint research and social implementation of novel blood-based biomarkers in the field of neurodegenerative diseases.
![Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy](https://reseuro.magzter.com/100x125/articles/11639/1979239/upC1wTjFx1738321380430/JAPAN-GIVES-NOD-TO-FIRST-SUBCUTANEOUS-IMMUNOGLOBULIN-FSCIG-THERAPY.jpg)
Japan gives nod to first subcutaneous immunoglobulin (fSCIG) therapy
Japanese Ministry of Health, Labour and Welfare has approved the use of Takeda's HYQVIA [Immune Globulin Infusion 10 percent (Human) with Recombinant Human Hyaluronidase] in patients with agammaglobulinemia or hypogammaglobulinemia, disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency (PID) or secondary immunodeficiency (SID).
![UAE nears completion of National Health Survey UAE nears completion of National Health Survey](https://reseuro.magzter.com/100x125/articles/11639/1979239/SXhUS-5fW1738321326855/UAE-NEARS-COMPLETION-OF-NATIONAL-HEALTH-SURVEY.jpg)
UAE nears completion of National Health Survey
The Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) has announced a significant milestone in its national surveys project, with 95 percent completion rate for the National Health Survey and 78 percent for the National Nutrition Survey, marking a significant step toward building a robust health database.
![Julia Wang steps in as Executive Vice President and CFO at Labcorp Julia Wang steps in as Executive Vice President and CFO at Labcorp](https://reseuro.magzter.com/100x125/articles/11639/1979239/7OqUE_z-h1738327692320/JULIA-WANG-STEPS-IN-AS-EXECUTIVE-VICE-PRESIDENT-AND-CFO-AT-LABCORP.jpg)
Julia Wang steps in as Executive Vice President and CFO at Labcorp
Labcorp, a global leader of innovative and comprehensive laboratory services, has announced that Executive Vice President and Chief Financial Officer (CFO) Glenn Eisenberg has retired from the company and Julia Wang has joined this position.
![Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt](https://reseuro.magzter.com/100x125/articles/11639/1979239/qUFRiyMDu1738321852419/NEUBERG-DIAGNOSTICS-SECURES-RS-940-CR-FROM-KOTAK-ALT.jpg)
Neuberg Diagnostics secures Rs 940 Cr from Kotak Alt
Neuberg Diagnostics has secured Rs 940 crore from Kotak Alt in the largest-ever primary fund-raise in the Indian diagnostics sector.
![RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool](https://reseuro.magzter.com/100x125/articles/11639/1979239/tcOK4Kjjw1738322236010/RNT-HEALTH-INSIGHTS-RECEIVES-2ND-US-FDA-BDD-FOR-OESOPHAGEAL-CANCER-DETECTION-TOOL.jpg)
RNT Health Insights receives 2nd US FDA BDD for oesophageal cancer detection tool
RNT Health Insights, an Indian health-tech startup specialising in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation (BDD) for its Oesophageal Cancer detection tool.
![Middle East: A rising powerhouse in Medtech and Diagnostics. Middle East: A rising powerhouse in Medtech and Diagnostics.](https://reseuro.magzter.com/100x125/articles/11639/1979239/fS7Z0xLhE1738326937178/MIDDLE-EAST-A-RISING-POWERHOUSE-IN-MEDTECH-AND-DIAGNOSTICS.jpg)
Middle East: A rising powerhouse in Medtech and Diagnostics.
The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments.
![Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing](https://reseuro.magzter.com/100x125/articles/11639/1979239/ceGLfvKji1738322270281/ALEBUND-PHARMACEUTICALS-ANNOUNCES-FIRST-CLOSING-OF-RMB-550-M-IN-SERIES-C-FINANCING.jpg)
Alebund Pharmaceuticals announces first closing of RMB 550 M in Series C financing
Shanghai-based Alebund Pharmaceuticals, an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, has announced the closing of RMB 550 million in Series C financing.
![IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes](https://reseuro.magzter.com/100x125/articles/11639/1979239/NCgkZPT2f1738327453214/IITB-JOINS-HANDS-WITH-TOHOKU-UNIVERSITY-TO-OFFER-MTECH-PHD-DUAL-DEGREE-PROGRAMMES.jpg)
IIT-B joins hands with Tohoku University to offer MTech, PhD dual degree programmes
The Indian Institute of Technology, Bombay (IIT-B) has entered into a Memorandum of Understanding (MoU) with Japan's Tohoku University to launch the IIT Bombay-Tohoku University Joint Academic & Research Programme.
![Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia](https://reseuro.magzter.com/100x125/articles/11639/1979239/ER-3bSV9a1738322076517/BIOTHERA-SOLUTIONS-TABUK-PHARMA-TO-COMMERCIALISE-STELARA-BIOSIMILAR-IN-SAUDI-ARABIA.jpg)
Bio-Thera Solutions & Tabuk Pharma to commercialise Stelara biosimilar in Saudi Arabia
China-based Bio-Thera Solutions Inc.,